Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)

Xiangxue Pharmaceutical Revenue

Xiangxue Pharmaceutical had revenue of 361.35M CNY in the quarter ending September 30, 2026, with 10.19% growth. This brings the company's total for the last twelve months to 1.51B, up 2.90% year-over-year. In the year 2025, Xiangxue Pharmaceutical had annual revenue of 1.60B, down -14.16%. That makes Xiangxue Pharmaceutical the 16,567th largest company in the world by revenue and 3,008th in China.

• Revenue (ttm): 1.51B
• Revenue Growth: +2.90%
• P/S Ratio: 2.12
• Revenue / Employee: 568.60K
• Employees: 2,662
• Market Cap: 3.21B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Chinese Herbal Medicines 990.74M 52.9%
• Pharmaceutical Manufacturing 430.57M 23.0%
• Others 357.75M 19.1%
• Pharmaceutical Distribution 75.61M 4.0%
• Medical Instruments 19.00M 1.0%

By Geography

Chart

• Northern China, Eastern China, and The Northeastern China 1.06B 66.2%
• Guangdong Province 387.16M 24.3%
• Central China 89.41M 5.6%
• Southwest Region 62.56M 3.9%

Fiscal year ended Dec 31, 2025 See the full Xiangxue Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.60B	-263.25M	-14.16%
Dec 31, 2024	1.86B	-440.63M	-19.16%
Dec 31, 2023	2.30B	112.22M	5.13%
Jan 1, 2023	2.19B	-783.51M	-26.38%
Jan 1, 2022	2.97B	-101.51M	-3.30%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error